Last reviewed · How we verify
Retin-A Micro 0.04% facial acne treatment
Retin-A Micro 0.04% facial acne treatment is a Small molecule drug developed by Bausch Health Americas, Inc.. It is currently in Phase 2 development. Also known as: facial acne treatment.
At a glance
| Generic name | Retin-A Micro 0.04% facial acne treatment |
|---|---|
| Also known as | facial acne treatment |
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris (PHASE1)
- Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face (PHASE4)
- Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face (PHASE4)
- A Study of Different Use Regimens Using Two Acne Treatments (PHASE4)
- A Study of Acne Treatment in Children Ages 9 to 11 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Retin-A Micro 0.04% facial acne treatment CI brief — competitive landscape report
- Retin-A Micro 0.04% facial acne treatment updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI
Frequently asked questions about Retin-A Micro 0.04% facial acne treatment
What is Retin-A Micro 0.04% facial acne treatment?
Retin-A Micro 0.04% facial acne treatment is a Small molecule drug developed by Bausch Health Americas, Inc..
Who makes Retin-A Micro 0.04% facial acne treatment?
Retin-A Micro 0.04% facial acne treatment is developed by Bausch Health Americas, Inc. (see full Bausch Health Americas, Inc. pipeline at /company/bausch-health-americas-inc).
Is Retin-A Micro 0.04% facial acne treatment also known as anything else?
Retin-A Micro 0.04% facial acne treatment is also known as facial acne treatment.
What development phase is Retin-A Micro 0.04% facial acne treatment in?
Retin-A Micro 0.04% facial acne treatment is in Phase 2.
Related
- Manufacturer: Bausch Health Americas, Inc. — full pipeline
- Also known as: facial acne treatment
- Compare: Retin-A Micro 0.04% facial acne treatment vs similar drugs
- Pricing: Retin-A Micro 0.04% facial acne treatment cost, discount & access